PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1979 January; 72(1): 27–34.
PMCID: PMC1436756

Role of prostaglandins in bone metabolism: a review.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (928K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Atkins D, Hunt NH, Ingleton PM, Martin TJ. Rat osteogenic sarcoma cells: isolation and effects of hormones on the production of cyclic AMP and cyclic GMP. Endocrinology. 1977 Aug;101(2):555–561. [PubMed]
  • Atkins D, Ibbotson KJ, Hillier K, Hunt NH, Hammonds JC, Martin TJ. Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in culture. Br J Cancer. 1977 Nov;36(5):601–607. [PMC free article] [PubMed]
  • Beliel OM, Singer FR, Coburn JW. Prostaglandins: effect on plasma calcium concentration. Prostaglandins. 1973 Feb;3(2):237–241. [PubMed]
  • Bennett A, McDonald AM, Simpson JS, Stamford IF. Breast cancer, prostaglandins, and bone metastases. Lancet. 1975 May 31;1(7918):1218–1220. [PubMed]
  • Brereton HD, Halushka PV, Alexander RW, Mason DM, Keiser HR, DeVita VT., Jr Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma. N Engl J Med. 1974 Jun 11;291(2):83–85. [PubMed]
  • Buckle RM, McMillan M, Mallinson C. Ectopic secretion of parathyroid hormone by a renal adenocarcinoma in a patient with hypercalcaemia. Br Med J. 1970 Dec 19;4(5737):724–726. [PMC free article] [PubMed]
  • Chase LR, Aurbach GD. The effect of parathyroid hormone on the concentration of adenosine 3',5'-monophosphate in skeletal tissue in vitro. J Biol Chem. 1970 Apr 10;245(7):1520–1526. [PubMed]
  • Coombes RC, Neville AM, Bondy PK, Powles TJ. Failure of indomethacin to reduce hypercalcemia in patients with breast cancer. Prostaglandins. 1976 Dec;12(6):1027–1035. [PubMed]
  • Demers LM, Allegra JC, Harvey HA, Lipton A, Luderer JR, Mortel R, Brenner DE. Plasma prostaglandins in hypercalcemic patients with neoplastic disease. Cancer. 1977 Apr;39(4):1559–1562. [PubMed]
  • Dietrich JW, Goodson JM, Raisz LG. Stimulation of bone resorption by various prostaglandins in organ culture. Prostaglandins. 1975 Aug;10(2):231–240. [PubMed]
  • Galasko CS, Bennett A. Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins. Nature. 1976 Oct 7;263(5577):508–510. [PubMed]
  • Gordon GS, Cantino RJ, Erhardt L, Hansen J, Lubich W. Osteolytic sterol in human breast cancer. Science. 1966 Mar 11;151(3715):1226–1228. [PubMed]
  • Gryglewski RJ, Bunting S, Moncada S, Flower RJ, Vane JR. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins. 1976 Nov;12(5):685–713. [PubMed]
  • Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994–2998. [PubMed]
  • Hunt NH, Shortland JR, Michelangeli VP, Hammonds JC, Atkins D, Martin TJ. Adenylate cyclase activity of renal cortical carcinoma and its relation to histology and ultrastructure. Cancer Res. 1978 Jan;38(1):23–31. [PubMed]
  • Knill-Jones RP, Buckle RM, Parsons V, Calne RY, Williams R. Hypercalcemia and increased parathyroid-hormone activity in a primary hepatoma. Studies before and after hepatic transplantation. N Engl J Med. 1970 Mar 26;282(13):704–708. [PubMed]
  • Martin TJ, Ingleton PM, Underwood JC, Michelangeli VP, Hunt NH, Melick RA. Parathyroid hormone-responsive adenylate cyclase in induced transplantable osteogenic rat sarcoma. Nature. 1976 Apr 1;260(5550):436–438. [PubMed]
  • Mundy GR, Luben RA, Raisz LG, Oppenheim JJ, Buell DN. Bone-resorbing activity in supernatants from lymphoid cell lines. N Engl J Med. 1974 Apr 18;290(16):867–871. [PubMed]
  • Mundy GR, Raisz LG, Cooper RA, Schechter GP, Salmon SE. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med. 1974 Nov 14;291(20):1041–1046. [PubMed]
  • Powell D, Singer FR, Murray TM, Minkin C, Potts JT., Jr Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases. N Engl J Med. 1973 Jul 26;289(4):176–181. [PubMed]
  • Powles TJ, Clark SA, Easty DM, Easty GC, Neville AM. The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer. Br J Cancer. 1973 Oct;28(4):316–321. [PMC free article] [PubMed]
  • Raisz LG, Dietrich JW, Simmons HA, Seyberth HW, Hubbard W, Oates JA. Effect of prostaglaidin endoperoxides and metabolites on bone resorption in vitro. Nature. 1977 Jun 9;267(5611):532–534. [PubMed]
  • Robertson RP, Baylink DJ, Marini BJ, Adkison HW. Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma. J Clin Endocrinol Metab. 1975 Jul;41(1):164–167. [PubMed]
  • Robinson CJ, Parsons JA. Proceedings: Lack of hypercalcaemia on infusing prostaglandin E2 to rats, argues against its suggested role in the 'non-parathyroid hypercalcaemic tumour' syndrome. J Endocrinol. 1975 Jan;64(1):14P–15P. [PubMed]
  • Sato S, Szabo M, Kowalski K, Burke G. Role of prostaglandin in thyrotropin action on thyroid. Endocrinology. 1972 Feb;90(2):343–356. [PubMed]
  • Seyberth HW, Segre GV, Morgan JL, Sweetman BJ, Potts JT, Jr, Oates JA. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med. 1975 Dec 18;293(25):1278–1283. [PubMed]
  • Tashjian AH, Jr, Tice JE, Sides K. Biological activities of prostaglandin analogues and metabolites on bone in organ culture. Nature. 1977 Apr 14;266(5603):645–647. [PubMed]
  • Tashjian AH, Jr, Voelkel EF, Levine L. Effects of hydrocortisone on the hypercalcemia and plasma levels of 13,14-dihydro-15-keto-prostaglandin E2 in mice bearing the HSDM1 fibrosarcoma. Biochem Biophys Res Commun. 1977 Jan 10;74(1):199–207. [PubMed]
  • Tashjian AH, Jr, Voelkel EF, Levine L, Goldhaber P. Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer. J Exp Med. 1972 Dec 1;136(6):1329–1343. [PMC free article] [PubMed]
  • Tashjian AH, Jr, Voelkel EF, Goldhaber P, Levine L. Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma. Prostaglandins. 1973 Apr;3(4):515–524. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press